Choksi Asia Limited
BSE: CHOKSI · Medical Equipment & Supplies · sector
Key numbers
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 15 companies in Medical Equipment & Supplies (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹7 cr vs borrowings ₹2 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 21.9x in the last 12 months.
- Other income was 27% of net profit in the last 12 months.
- Dividend paid in 1 of the last 5 financial years.
- Price ₹202.00 on 2026-10-26: -24.2% from the 52-week high, +109.1% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 12 | 12 | 13 | 12 | 12 | 9 |
| EBITDA | 1 | 1 | 2 | 2 | 2 | 1 |
| OPM % | 10.3% | 11.7% | 12.0% | 14.6% | 16.9% | 15.0% |
| Other income | 0 | 0 | 0 | 1 | 0 | 0 |
| Net profit | 1 | 1 | 1 | 2 | 1 | 1 |
| EPS (₹) | 1.24 | 1.88 | 2.36 | 3.73 | 1.32 | 1.69 |
| Revenue YoY | -2.4% | -22.5% | ||||
| Profit YoY | +5.6% | -10.3% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 2 | 1 | 1 | 37 | 49 | 47 |
| EBITDA | -2 | -1 | -2 | 4 | 7 | 7 |
| Net profit | -0 | -0 | -0 | 3 | 5 | 5 |
| EPS (₹) | -1.08 | -1.22 | -1.17 | 5.44 | 9.36 | 9.10 |
| Revenue growth | -61.9% | +64.9% | +2,811.8% | +33.3% | – | |
| Profit growth | – | – | – | +72.5% | – | |
| Dividend / share (₹) | 2.50 | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +300.1% | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | +72.1% (2y) | +90.9% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 37 | 42 |
| Borrowings | 5 | 2 |
| Cash & equivalents | 10 | 7 |
| Total assets | 47 | 47 |
| Fixed assets | 6 | 7 |
| Capital work in progress | 0 | 0 |
| Investments | 0 | 0 |
| Receivables | 8 | 9 |
| Inventory | 9 | 9 |
| Payables | 3 | 1 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | -3 | 1 |
| Cash from investing | 1 | 0 |
| Cash from financing | -1 | -3 |
| Capex | 1 | 1 |
| Free cash flow | -4 | -0 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 8.4% | 12.7% |
| ROCE % | 12.5% | 18.0% |
| Debtor days | 82 | 70 |
| Inventory days | 106 | 86 |
| Payable days | 39 | 14 |
| Cash conversion cycle (days) | 149 | 142 |
| Working capital days | 237 | 183 |
Peers in Medical Equipment & Supplies
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| POLYMED | ₹14,631 cr | 46.4x | 4.7x | 10.7% | 12.7% | 22.8% | +18.9% | 0.24% |
| MOLBIO | ₹14,360 cr | – | – | – | – | – | – | – |
| TARSONS | ₹1,587 cr | 142.7x | 2.5x | 1.8% | 4.1% | 26.8% | +14.3% | – |
| LAXMIDENTL | ₹945 cr | 30.4x | 3.9x | 13.7% | 13.4% | 14.0% | – | – |
| FISCHER | ₹856 cr | 11.2x | 2.2x | -0.8% | 11.6% | 13.6% | – | 0.04% |
| HSIL | ₹740 cr | 36.9x | 6.5x | 21.8% | 24.1% | 10.0% | – | – |
| FABTECH | ₹543 cr | 8.8x | 1.3x | 11.6% | 13.6% | 10.9% | – | – |
| PREVEST | ₹455 cr | 14.7x | 4.0x | 29.9% | 36.9% | 34.1% | +12.9% | 0.26% |
| NURECA | ₹296 cr | 63.0x | 1.6x | 2.5% | 5.3% | 3.5% | +9.7% | – |
| CHOKSI | ₹115 cr | 22.2x | 2.7x | 13.1% | 17.9% | 14.5% | +300.1% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2021-09-16 | Dividend | Final Dividend Rs 2.5 |
| 2019-09-05 | Dividend | Final Dividend Rs 0.5 |
| 2018-09-17 | Dividend | Final Dividend Rs 0.75 |
| 2017-09-14 | Dividend | Final Dividend Rs 0.75 |
| 2016-09-15 | Dividend | Dividend Rs 1.0 |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Medical Equipment & Supplies |
| Sub-industry | Medical Equipment & Supplies |
| Symbol | CHOKSI |
| BSE code | 530427 |
| ISIN | INE865B01016 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.